Adrenal suppression and failure to thrive after steroid injections for periocular hemangioma.

Ophthalmology

Department of Ophthalmology, University Hospital of Wales, Heath Park, Cardiff CF14 4XW, United Kingdom.

Published: February 2004

Purpose: To evaluate the effects of steroid injections for periocular capillary hemangioma on adrenal function and body composition.

Design: Noncomparative, interventional case series.

Participants: Four patients with periocular hemangioma.

Methods: Four white female infants with sight-threatening periocular hemangiomata received a combination of steroid injections of triamcinolone and betamethasone. In the first 2 cases, injections were perilesional and in the other 2, intralesional.

Main Outcome Measures: The infants were monitored by serial measurements of basal serum cortisol concentrations, responses to the Synacthen stimulation test, measurement of growth and of weight gain, and, in one case, more detailed anthropometric measures of body composition.

Results: Prolonged suppression of circulating serum cortisol concentrations and cortisol responses to the Synacthen stimulation test were noted in 3 cases, and marked failure to thrive was noted in all 4 cases.

Conclusions: Adrenal suppression after steroid injection for periocular capillary hemangioma is a potentially life-threatening complication. Failure to thrive is also a frequent side effect of treatment. Ophthalmologists should undertake the above treatment in consultation with a pediatric endocrinologist.

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0161-6420(03)00833-9DOI Listing

Publication Analysis

Top Keywords

failure thrive
12
steroid injections
12
adrenal suppression
8
injections periocular
8
periocular capillary
8
capillary hemangioma
8
serum cortisol
8
cortisol concentrations
8
responses synacthen
8
synacthen stimulation
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!